Ashurst prepares Protherics for potential takeover
Leading UK biotechnology company Protherics has called on Ashurst as it embarks on takeover talks. The company saw its share price leap 44 per cent after announcing it had received several approaches from unnamed parties. Any deal would have to value Protherics at more than its market price of around £130m. Ashurst corporate partners Andrew […]